How much does Tepnel Pharma Services Limited make?

Tepnel Pharma Services Limited reported revenue of £3.4m and £248k profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Tepnel Pharma Services Limited have?

Tepnel Pharma Services Limited reported an average of 30 employees in the year to 31 Dec 2025.

Is Tepnel Pharma Services Limited profitable?

Yes — Tepnel Pharma Services Limited reported a profit of £248k in the year to 31 Dec 2025.

Company No. SC635641 · Incorporated 9 Jul 2019

Tepnel Pharma Services Limited

Registered name: TEPNEL PHARMA SERVICES LIMITED

Part of Tepnel Life Sciences Trustees Limited group

Tepnel Pharma Services Limited made £3.4m revenue and £248k profit in the year to 31 Dec 2025.

Tepnel Pharma Services Limited’s revenue fell 1% to £3.4m in the year to 31 Dec 2025, with £248k profit and 30 employees. The company is classified under “other professional, scientific and technical activities” and is based in Glasgow; we hold 4 years of its filed accounts.

Full P&L filedSection M · Professional, scientific and technical activitiesSIC 74909Other professional, scientific and technical activities n.e.c.

Status: Active
Location: Glasgow, Scotland
Age: 7 yrs · since 2019
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Capital-light

Revenue

£3.4m

Growth ▼0.9%

Profit

£248k

Growth ▲17.3%

Profit margin

7.3%

Gross 51.1%

Employees

Change ▼3.2%

Profit / employee

£8.3k

Revenue/employee £113k

Profitable streak

4yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£3.1m	£3.2m	£3.4m	£3.4m
Cost of sales	£1.6m	£1.6m	£1.7m	£1.7m
Gross profit	£1.5m	£1.6m	£1.7m	£1.7m
Operating profit	£305k	£287k	£289k	£337k
Profit before tax	£304k	£287k	£289k	£338k
Profit after tax	£245k	£224k	£211k	£248k
Profit (best available)	£245k	£224k	£211k	£248k
Employees (average)	35	32	31	30
Ratios
Profit margin	7.9%	7.1%	6.2%	7.3%
Gross margin	48.6%	49.9%	49.4%	51.1%
Revenue per employee	£88.7k	£98.5k	£110k	£113k
Profit per employee	£7k	£7k	£6.8k	£8.3k
Growth (year on year)
Revenue growth	—	▲1.5%	▲8.6%	▼0.9%
Profit growth	—	▼8.6%	▼5.5%	▲17.3%
Headcount growth	—	▼8.6%	▼3.1%	▼3.2%
Balance sheet — indirect signals, not revenue
Cash at bank	£777k	£623k	£656k	£835k
Net assets	£1.1m	£1m	£910k	£974k
Fixed assets	£72.4k	£111k	£98.8k	£78.5k
Current assets	£1.6m	£1.5m	£1.5m	£1.5m
Debtors	£509k	£438k	£567k	£326k
Deferred income	£342k	£307k	£331k	£333k
Source	FullAccounts · bulk data Jun 2024	FullAccounts · bulk data Jun 2024	FullAccounts · bulk data Sep 2025	FullAccounts · bulk data Jul 2026

Derived from the latest filing

How the business works

Profit margin: 7.3%; Profit ÷ revenue.
Gross margin: 51.1%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £113k; Revenue ÷ average employees.
Profit per employee: £8.3k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 2.3%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 9.8%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 9.6%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲7%; Now £974k
Cash at bank: ▲27%; Now £835k
Headcount: ▼3%; Now 30
Deferred income: ▲1%; Now £333k
Fixed assets: ▼21%; Now £78.5k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Tepnel Life Sciences Trustees Limitedultimate parent75–100%
Tepnel Pharma Services Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £248k), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.